For two decades, millions with milder asthma inhaled steroid medicine daily to reduce inflammation, but U.S. researchers say it doesn\'t help. The study, published in The Journal of the American Medical Association, found asthmatics who took low-dose medication as a daily routine did no better than those who turned to their inhalers only when they have symptoms. Senior author Dr. Homer A. Boushey of the University of California, San Francisco, said the findings challenge national and international guidelines that have been in place for 20 years. These recommendations said if a person\'s asthma was mild but persistent, he or she should take an inhaled steroid every day to suppress airway inflammation and reduce the risk of exacerbations. \"Daily treatment with an inhaled corticosteroid has long been believed to be the best treatment for mild persistent asthma, but it is not followed by the majority of patients,\'\' Boushey said in a statement. Altogether, 342 adults with mild to moderate, persistent asthma took part in the study over nine months during the period of 2007 to 2010. All were diagnosed by physicians and all had either reversible airflow limitation or airway hyperresponsiveness. The researchers found the frequency of flare-ups or exacerbations of asthma, symptom severity and pulmonary function did not differ among the treatment groups.
GMT 14:01 2018 Thursday ,30 August
Expat with rare heart disorder gets life-saving surgeryGMT 00:18 2018 Tuesday ,23 January
Boy with 10-pound tumour on face diesGMT 21:23 2018 Monday ,22 January
All set for first global medical tourism conference in DubaiGMT 22:46 2018 Sunday ,21 January
Second face transplant for FrenchmanGMT 07:51 2018 Saturday ,20 January
Trio aquitted of negligence in Canada railway disasterGMT 10:57 2018 Thursday ,18 January
Breastfeeding for 6 months cuts diabetes risk in half: studyGMT 16:10 2018 Wednesday ,17 January
Child mummy in Italy had hepatitis, not smallpoxGMT 18:36 2018 Tuesday ,16 January
Greece strikes cause transport chaos, healthcare delays

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor